nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—multiple sclerosis	0.869	1	CbGaD
Mimosine—TYR—retina—multiple sclerosis	0.00427	0.195	CbGeAlD
Mimosine—CCL2—IL23-mediated signaling events—IL23A—multiple sclerosis	0.00422	0.0413	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—AHI1—multiple sclerosis	0.00256	0.0251	CbGpPWpGaD
Mimosine—CCL2—retina—multiple sclerosis	0.00245	0.112	CbGeAlD
Mimosine—CCL2—GMCSF-mediated signaling events—IRF8—multiple sclerosis	0.00228	0.0223	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCR1—multiple sclerosis	0.0021	0.0205	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CXCL13—multiple sclerosis	0.0021	0.0205	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—STAT4—multiple sclerosis	0.00201	0.0196	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL17A—multiple sclerosis	0.00198	0.0193	CbGpPWpGaD
Mimosine—SHMT1—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00197	0.0193	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL12B—multiple sclerosis	0.00184	0.018	CbGpPWpGaD
Mimosine—CCL2—medulla oblongata—multiple sclerosis	0.00177	0.0811	CbGeAlD
Mimosine—CCL2—midbrain—multiple sclerosis	0.00162	0.0741	CbGeAlD
Mimosine—CCL2—spinal cord—multiple sclerosis	0.00158	0.0723	CbGeAlD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCL3—multiple sclerosis	0.0015	0.0146	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—ICAM1—multiple sclerosis	0.00147	0.0144	CbGpPWpGaD
Mimosine—SHMT1—nervous system—multiple sclerosis	0.00144	0.0658	CbGeAlD
Mimosine—CCL2—Spinal Cord Injury—MBP—multiple sclerosis	0.00142	0.0139	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CXCR3—multiple sclerosis	0.00139	0.0136	CbGpPWpGaD
Mimosine—SHMT1—central nervous system—multiple sclerosis	0.00138	0.0633	CbGeAlD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCR2—multiple sclerosis	0.00135	0.0132	CbGpPWpGaD
Mimosine—SHMT1—cerebellum—multiple sclerosis	0.00135	0.0619	CbGeAlD
Mimosine—CCL2—nervous system—multiple sclerosis	0.00133	0.0609	CbGeAlD
Mimosine—CCL2—central nervous system—multiple sclerosis	0.00128	0.0587	CbGeAlD
Mimosine—CCL2—cerebellum—multiple sclerosis	0.00125	0.0574	CbGeAlD
Mimosine—CCL2—TWEAK Signaling Pathway—CCL5—multiple sclerosis	0.00122	0.0119	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—SELE—multiple sclerosis	0.00117	0.0114	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CXCL10—multiple sclerosis	0.00112	0.011	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—IFNG—multiple sclerosis	0.00112	0.0109	CbGpPWpGaD
Mimosine—SHMT1—brain—multiple sclerosis	0.0011	0.0503	CbGeAlD
Mimosine—CCL2—Spinal Cord Injury—AQP4—multiple sclerosis	0.00108	0.0105	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.00104	0.0102	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNFAIP3—multiple sclerosis	0.00103	0.0101	CbGpPWpGaD
Mimosine—CCL2—brain—multiple sclerosis	0.00102	0.0466	CbGeAlD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—IL1B—multiple sclerosis	0.000996	0.00975	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL4—multiple sclerosis	0.000992	0.00971	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCL5—multiple sclerosis	0.000968	0.00947	CbGpPWpGaD
Mimosine—CCL2—IL1 and megakaryotyces in obesity—MMP9—multiple sclerosis	0.000939	0.00919	CbGpPWpGaD
Mimosine—CCL2—Chemokine receptors bind chemokines—CCR5—multiple sclerosis	0.000872	0.00853	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.000855	0.00836	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNFRSF1A—multiple sclerosis	0.000845	0.00827	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—TYK2—multiple sclerosis	0.000843	0.00825	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL4—multiple sclerosis	0.000822	0.00805	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL10—multiple sclerosis	0.000806	0.00789	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.000803	0.00786	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.00079	0.00773	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.00079	0.00773	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IFNG—multiple sclerosis	0.00079	0.00773	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—ICAM1—multiple sclerosis	0.000788	0.00771	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL4—multiple sclerosis	0.000784	0.00768	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—CD4—multiple sclerosis	0.000763	0.00746	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000745	0.00729	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000719	0.00703	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—HLA-A—multiple sclerosis	0.000711	0.00695	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—CCL2—multiple sclerosis	0.000705	0.0069	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL1B—multiple sclerosis	0.000704	0.00689	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL2—multiple sclerosis	0.000702	0.00687	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.000669	0.00655	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—multiple sclerosis	0.000664	0.0065	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—ALB—multiple sclerosis	0.000657	0.00643	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—ICAM1—multiple sclerosis	0.000653	0.00639	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000619	0.00606	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.000611	0.00598	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MMP9—multiple sclerosis	0.0006	0.00587	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IFNG—multiple sclerosis	0.0006	0.00587	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—STAT3—multiple sclerosis	0.000591	0.00578	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—STAT3—multiple sclerosis	0.000591	0.00578	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000579	0.00567	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.000563	0.00551	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—BDNF—multiple sclerosis	0.000556	0.00544	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000547	0.00536	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.000545	0.00533	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—ALB—multiple sclerosis	0.000545	0.00533	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—TYK2—multiple sclerosis	0.000537	0.00526	CbGpPWpGaD
Mimosine—CCL2—GMCSF-mediated signaling events—MAPK1—multiple sclerosis	0.000537	0.00525	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL1B—multiple sclerosis	0.000535	0.00524	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL2—multiple sclerosis	0.000533	0.00522	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00053	0.00519	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00053	0.00519	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.000523	0.00512	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000519	0.00508	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL4—multiple sclerosis	0.000517	0.00506	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—IL1B—multiple sclerosis	0.000513	0.00502	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—TNF—multiple sclerosis	0.000511	0.005	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.000509	0.00498	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IFNG—multiple sclerosis	0.000497	0.00486	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—MAPK1—multiple sclerosis	0.000485	0.00475	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IFNG—multiple sclerosis	0.000474	0.00464	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—TNF—multiple sclerosis	0.000462	0.00452	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL1B—multiple sclerosis	0.000443	0.00434	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL2—multiple sclerosis	0.000442	0.00432	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—GPR65—multiple sclerosis	0.000441	0.00432	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MMP9—multiple sclerosis	0.000437	0.00428	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000433	0.00423	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TLR4—multiple sclerosis	0.000428	0.00419	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.000423	0.00414	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL2—multiple sclerosis	0.000421	0.00412	CbGpPWpGaD
Mimosine—CCL2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—multiple sclerosis	0.000412	0.00404	CbGpPWpGaD
Mimosine—CCL2—IL23-mediated signaling events—IL6—multiple sclerosis	0.000412	0.00404	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—ICAM1—multiple sclerosis	0.00041	0.00402	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL13—multiple sclerosis	0.000404	0.00395	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR1—multiple sclerosis	0.000404	0.00395	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MMP9—multiple sclerosis	0.000399	0.0039	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.000395	0.00387	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000395	0.00386	CbGpPWpGaD
Mimosine—CCL2—IL-1 signaling pathway—MAPK1—multiple sclerosis	0.000391	0.00383	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—TNF—multiple sclerosis	0.000388	0.0038	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000378	0.0037	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—STAT3—multiple sclerosis	0.000376	0.00368	CbGpPWpGaD
Mimosine—CCL2—TWEAK Signaling Pathway—IL6—multiple sclerosis	0.000373	0.00365	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.000364	0.00356	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000363	0.00356	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SRM—multiple sclerosis	0.000362	0.00354	CbGpPWpGaD
Mimosine—SHMT1—Validated targets of C-MYC transcriptional activation—MYC—multiple sclerosis	0.000361	0.00353	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000352	0.00345	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000351	0.00344	CbGpPWpGaD
Mimosine—CCL2—Oncostatin M Signaling Pathway—MAPK1—multiple sclerosis	0.000342	0.00335	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000341	0.00334	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000334	0.00327	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—MYC—multiple sclerosis	0.000329	0.00322	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—TGFB1—multiple sclerosis	0.000329	0.00322	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.000328	0.00321	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—TNF—multiple sclerosis	0.000322	0.00315	CbGpPWpGaD
Mimosine—CCL2—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.000319	0.00312	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000315	0.00308	CbGpPWpGaD
Mimosine—SHMT1—Folate Metabolism—IL6—multiple sclerosis	0.000313	0.00307	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IFNG—multiple sclerosis	0.000312	0.00306	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL3—multiple sclerosis	0.000288	0.00281	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000284	0.00278	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—S1PR1—multiple sclerosis	0.000281	0.00275	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL1B—multiple sclerosis	0.000279	0.00273	CbGpPWpGaD
Mimosine—SHMT1—Disease—GPC5—multiple sclerosis	0.000278	0.00272	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL2—multiple sclerosis	0.000277	0.00272	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—PTGER4—multiple sclerosis	0.000277	0.00271	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—PABPC1—multiple sclerosis	0.00027	0.00264	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCR3—multiple sclerosis	0.000267	0.00262	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MMP9—multiple sclerosis	0.000263	0.00257	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCR2—multiple sclerosis	0.00026	0.00254	CbGpPWpGaD
Mimosine—CCL2—Folate Metabolism—IL6—multiple sclerosis	0.00026	0.00254	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—MAPK1—multiple sclerosis	0.000259	0.00253	CbGpPWpGaD
Mimosine—CCL2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.000256	0.00251	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000256	0.0025	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP27B1—multiple sclerosis	0.000255	0.00249	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYP24A1—multiple sclerosis	0.000255	0.00249	CbGpPWpGaD
Mimosine—CCL2—AP-1 transcription factor network—IL6—multiple sclerosis	0.000248	0.00242	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—TNF—multiple sclerosis	0.000247	0.00241	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000244	0.00239	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—RPL5—multiple sclerosis	0.000244	0.00238	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CNR1—multiple sclerosis	0.00024	0.00235	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—RGS1—multiple sclerosis	0.000239	0.00234	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GPC5—multiple sclerosis	0.000233	0.00228	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GPR65—multiple sclerosis	0.000226	0.00222	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00022	0.00215	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LINGO1—multiple sclerosis	0.000219	0.00214	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MYC—multiple sclerosis	0.000217	0.00212	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000216	0.00212	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CXCL10—multiple sclerosis	0.000216	0.00211	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—MAPK1—multiple sclerosis	0.000212	0.00208	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR1—multiple sclerosis	0.000207	0.00203	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL13—multiple sclerosis	0.000207	0.00203	CbGpPWpGaD
Mimosine—CCL2—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000206	0.00202	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—TNF—multiple sclerosis	0.000202	0.00198	CbGpPWpGaD
Mimosine—CCL2—TNF alpha Signaling Pathway—IL6—multiple sclerosis	0.000199	0.00195	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—RRM1—multiple sclerosis	0.000193	0.00189	CbGpPWpGaD
Mimosine—CCL2—Ectoderm Differentiation—MYC—multiple sclerosis	0.000191	0.00187	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TAGAP—multiple sclerosis	0.00019	0.00186	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—CCL5—multiple sclerosis	0.000186	0.00182	CbGpPWpGaD
Mimosine—SHMT1—Disease—RPL5—multiple sclerosis	0.000181	0.00177	CbGpPWpGaD
Mimosine—CCL2—Metabolism of proteins—BCHE—multiple sclerosis	0.000178	0.00174	CbGpPWpGaD
Mimosine—CCL2—Methylprednisolone—Dexamethasone—multiple sclerosis	0.000174	0.0236	CbGdCrCtD
Mimosine—CCL2—Methylprednisolone—Betamethasone—multiple sclerosis	0.000174	0.0236	CbGdCrCtD
Mimosine—SHMT1—Disease—SLC11A1—multiple sclerosis	0.000173	0.0017	CbGpPWpGaD
Mimosine—CCL2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000172	0.00168	CbGpPWpGaD
Mimosine—CCL2—Methylprednisolone—Triamcinolone—multiple sclerosis	0.00017	0.023	CbGdCrCtD
Mimosine—CCL2—GPCR ligand binding—CCR5—multiple sclerosis	0.000168	0.00164	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—S1PR1—multiple sclerosis	0.000166	0.00162	CbGpPWpGaD
Mimosine—CCL2—Spinal Cord Injury—IL6—multiple sclerosis	0.000163	0.0016	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GPC5—multiple sclerosis	0.000161	0.00158	CbGpPWpGaD
Mimosine—CCL2—Methylprednisolone—Prednisone—multiple sclerosis	0.000161	0.0219	CbGdCrCtD
Mimosine—CCL2—Methylprednisolone—Prednisolone—multiple sclerosis	0.000157	0.0213	CbGdCrCtD
Mimosine—CCL2—Beclomethasone—Dexamethasone—multiple sclerosis	0.000156	0.0211	CbGdCrCtD
Mimosine—CCL2—Beclomethasone—Betamethasone—multiple sclerosis	0.000156	0.0211	CbGdCrCtD
Mimosine—CCL2—Beclomethasone—Triamcinolone—multiple sclerosis	0.000152	0.0207	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—CCL3—multiple sclerosis	0.000148	0.00144	CbGpPWpGaD
Mimosine—CCL2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000146	0.0198	CbGdCrCtD
Mimosine—CCL2—Fluocinonide—Betamethasone—multiple sclerosis	0.000144	0.0195	CbGdCrCtD
Mimosine—CCL2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000144	0.0195	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000142	0.00139	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RGS1—multiple sclerosis	0.000141	0.00138	CbGpPWpGaD
Mimosine—CCL2—Beclomethasone—Prednisolone—multiple sclerosis	0.000141	0.0191	CbGdCrCtD
Mimosine—CCL2—Fluocinonide—Triamcinolone—multiple sclerosis	0.00014	0.0191	CbGdCrCtD
Mimosine—SHMT1—Disease—CD28—multiple sclerosis	0.000138	0.00135	CbGpPWpGaD
Mimosine—CCL2—Amcinonide—Betamethasone—multiple sclerosis	0.000138	0.0187	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Dexamethasone—multiple sclerosis	0.000138	0.0187	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000137	0.00134	CbGpPWpGaD
Mimosine—CCL2—Amcinonide—Triamcinolone—multiple sclerosis	0.000135	0.0183	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—GPR65—multiple sclerosis	0.000134	0.00131	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCR2—multiple sclerosis	0.000133	0.00131	CbGpPWpGaD
Mimosine—CCL2—GPCR ligand binding—POMC—multiple sclerosis	0.000131	0.00128	CbGpPWpGaD
Mimosine—CCL2—Amcinonide—Prednisone—multiple sclerosis	0.000128	0.0173	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Prednisolone—multiple sclerosis	0.000125	0.0169	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—CNR1—multiple sclerosis	0.000123	0.00121	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCL13—multiple sclerosis	0.000122	0.0012	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR1—multiple sclerosis	0.000122	0.0012	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000111	0.00109	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—BCHE—multiple sclerosis	0.000111	0.00109	CbGpPWpGaD
Mimosine—CCL2—Fluorometholone—Methylprednisolone—multiple sclerosis	0.000109	0.0148	CbGdCrCtD
Mimosine—CCL2—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.000109	0.0148	CbGdCrCtD
Mimosine—CCL2—Fluorometholone—Dexamethasone—multiple sclerosis	0.000108	0.0146	CbGdCrCtD
Mimosine—CCL2—Fluorometholone—Betamethasone—multiple sclerosis	0.000108	0.0146	CbGdCrCtD
Mimosine—CCL2—Flurandrenolide—Betamethasone—multiple sclerosis	0.000107	0.0145	CbGdCrCtD
Mimosine—CCL2—Flurandrenolide—Dexamethasone—multiple sclerosis	0.000107	0.0145	CbGdCrCtD
Mimosine—CCL2—Fluorometholone—Triamcinolone—multiple sclerosis	0.000105	0.0143	CbGdCrCtD
Mimosine—CCL2—Fluorometholone—Prednisone—multiple sclerosis	9.98e-05	0.0135	CbGdCrCtD
Mimosine—SHMT1—Disease—CD86—multiple sclerosis	9.87e-05	0.000966	CbGpPWpGaD
Mimosine—CCL2—Fluorometholone—Prednisolone—multiple sclerosis	9.75e-05	0.0132	CbGdCrCtD
Mimosine—CCL2—Flurandrenolide—Prednisolone—multiple sclerosis	9.69e-05	0.0131	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—CCL5—multiple sclerosis	9.55e-05	0.000934	CbGpPWpGaD
Mimosine—CCL2—Clobetasol propionate—Methylprednisolone—multiple sclerosis	9.25e-05	0.0126	CbGdCrCtD
Mimosine—CCL2—Metabolism of proteins—POMC—multiple sclerosis	9.21e-05	0.000902	CbGpPWpGaD
Mimosine—CCL2—Flunisolide—Methylprednisolone—multiple sclerosis	9.13e-05	0.0124	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Betamethasone—multiple sclerosis	9.11e-05	0.0124	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Dexamethasone—multiple sclerosis	9.11e-05	0.0124	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Methylprednisolone—multiple sclerosis	9.04e-05	0.0123	CbGdCrCtD
Mimosine—CCL2—Flunisolide—Betamethasone—multiple sclerosis	8.99e-05	0.0122	CbGdCrCtD
Mimosine—CCL2—Flunisolide—Dexamethasone—multiple sclerosis	8.99e-05	0.0122	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Triamcinolone—multiple sclerosis	8.9e-05	0.0121	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Dexamethasone—multiple sclerosis	8.9e-05	0.0121	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Betamethasone—multiple sclerosis	8.9e-05	0.0121	CbGdCrCtD
Mimosine—CCL2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	8.82e-05	0.012	CbGdCrCtD
Mimosine—CCL2—Flunisolide—Triamcinolone—multiple sclerosis	8.78e-05	0.0119	CbGdCrCtD
Mimosine—SHMT1—Disease—CCR5—multiple sclerosis	8.75e-05	0.000857	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL3—multiple sclerosis	8.72e-05	0.000853	CbGpPWpGaD
Mimosine—CCL2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	8.68e-05	0.0118	CbGdCrCtD
Mimosine—CCL2—Fluticasone Propionate—Betamethasone—multiple sclerosis	8.68e-05	0.0118	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—CCR5—multiple sclerosis	8.6e-05	0.000842	CbGpPWpGaD
Mimosine—CCL2—Desoximetasone—Methylprednisolone—multiple sclerosis	8.58e-05	0.0117	CbGdCrCtD
Mimosine—SHMT1—Disease—HLA-A—multiple sclerosis	8.53e-05	0.000835	CbGpPWpGaD
Mimosine—CCL2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	8.48e-05	0.0115	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—IL2RA—multiple sclerosis	8.48e-05	0.000829	CbGpPWpGaD
Mimosine—CCL2—Desoximetasone—Dexamethasone—multiple sclerosis	8.45e-05	0.0115	CbGdCrCtD
Mimosine—CCL2—Desoximetasone—Betamethasone—multiple sclerosis	8.45e-05	0.0115	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Prednisone—multiple sclerosis	8.45e-05	0.0115	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—PTGER4—multiple sclerosis	8.39e-05	0.000821	CbGpPWpGaD
Mimosine—CCL2—Flunisolide—Prednisone—multiple sclerosis	8.34e-05	0.0113	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Methylprednisolone—multiple sclerosis	8.33e-05	0.0113	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—PGR—multiple sclerosis	8.26e-05	0.000809	CbGpPWpGaD
Mimosine—CCL2—Desoximetasone—Triamcinolone—multiple sclerosis	8.26e-05	0.0112	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Prednisone—multiple sclerosis	8.25e-05	0.0112	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Prednisolone—multiple sclerosis	8.24e-05	0.0112	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Dexamethasone—multiple sclerosis	8.2e-05	0.0111	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Betamethasone—multiple sclerosis	8.2e-05	0.0111	CbGdCrCtD
Mimosine—CCL2—Flunisolide—Prednisolone—multiple sclerosis	8.14e-05	0.011	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CXCR3—multiple sclerosis	8.1e-05	0.000793	CbGpPWpGaD
Mimosine—CCL2—Triamcinolone—Prednisolone—multiple sclerosis	8.05e-05	0.0109	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CD28—multiple sclerosis	8.03e-05	0.000786	CbGpPWpGaD
Mimosine—CCL2—Diflorasone—Triamcinolone—multiple sclerosis	8.01e-05	0.0109	CbGdCrCtD
Mimosine—SHMT1—Disease—APOE—multiple sclerosis	7.96e-05	0.000779	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR2—multiple sclerosis	7.88e-05	0.000771	CbGpPWpGaD
Mimosine—CCL2—Desoximetasone—Prednisone—multiple sclerosis	7.83e-05	0.0106	CbGdCrCtD
Mimosine—CCL2—Desoximetasone—Prednisolone—multiple sclerosis	7.65e-05	0.0104	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Prednisone—multiple sclerosis	7.6e-05	0.0103	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Prednisolone—multiple sclerosis	7.42e-05	0.0101	CbGdCrCtD
Mimosine—CCL2—Budesonide—Methylprednisolone—multiple sclerosis	7.3e-05	0.00991	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CNR1—multiple sclerosis	7.28e-05	0.000712	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD80—multiple sclerosis	7.2e-05	0.000705	CbGpPWpGaD
Mimosine—CCL2—Budesonide—Betamethasone—multiple sclerosis	7.19e-05	0.00976	CbGdCrCtD
Mimosine—CCL2—Budesonide—Dexamethasone—multiple sclerosis	7.19e-05	0.00976	CbGdCrCtD
Mimosine—CCL2—Budesonide—Triamcinolone—multiple sclerosis	7.02e-05	0.00953	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—POMC—multiple sclerosis	6.72e-05	0.000658	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—APOE—multiple sclerosis	6.67e-05	0.000653	CbGpPWpGaD
Mimosine—CCL2—Budesonide—Prednisone—multiple sclerosis	6.67e-05	0.00905	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CXCL10—multiple sclerosis	6.55e-05	0.000641	CbGpPWpGaD
Mimosine—CCL2—Budesonide—Prednisolone—multiple sclerosis	6.51e-05	0.00883	CbGdCrCtD
Mimosine—SHMT1—Disease—TYK2—multiple sclerosis	6.08e-05	0.000595	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—TYK2—multiple sclerosis	5.97e-05	0.000584	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—POMC—multiple sclerosis	5.73e-05	0.000561	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CD86—multiple sclerosis	5.73e-05	0.000561	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL5—multiple sclerosis	5.64e-05	0.000552	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD4—multiple sclerosis	5.5e-05	0.000538	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALB—multiple sclerosis	5.22e-05	0.000511	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SPP1—multiple sclerosis	5.22e-05	0.000511	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR5—multiple sclerosis	5.08e-05	0.000497	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2RA—multiple sclerosis	5.01e-05	0.00049	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2—multiple sclerosis	4.97e-05	0.000486	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—APOE—multiple sclerosis	4.62e-05	0.000452	CbGpPWpGaD
Mimosine—CCL2—Betamethasone—Methylprednisolone—multiple sclerosis	4.47e-05	0.00606	CbGdCrCtD
Mimosine—CCL2—Dexamethasone—Methylprednisolone—multiple sclerosis	4.47e-05	0.00606	CbGdCrCtD
Mimosine—CCL2—Dexamethasone—Betamethasone—multiple sclerosis	4.4e-05	0.00597	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Dexamethasone—multiple sclerosis	4.4e-05	0.00597	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Triamcinolone—multiple sclerosis	4.3e-05	0.00583	CbGdCrCtD
Mimosine—CCL2—Dexamethasone—Triamcinolone—multiple sclerosis	4.3e-05	0.00583	CbGdCrCtD
Mimosine—SHMT1—Disease—STAT3—multiple sclerosis	4.26e-05	0.000417	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CD80—multiple sclerosis	4.18e-05	0.000409	CbGpPWpGaD
Mimosine—CCL2—Dexamethasone—Prednisone—multiple sclerosis	4.08e-05	0.00553	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Prednisone—multiple sclerosis	4.08e-05	0.00553	CbGdCrCtD
Mimosine—CCL2—Dexamethasone—Prednisolone—multiple sclerosis	3.98e-05	0.0054	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Prednisolone—multiple sclerosis	3.98e-05	0.0054	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—POMC—multiple sclerosis	3.97e-05	0.000389	CbGpPWpGaD
Mimosine—SHMT1—Disease—MYC—multiple sclerosis	3.96e-05	0.000387	CbGpPWpGaD
Mimosine—SHMT1—Disease—TGFB1—multiple sclerosis	3.95e-05	0.000386	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAPK1—multiple sclerosis	3.87e-05	0.000379	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAPK1—multiple sclerosis	3.8e-05	0.000372	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TYK2—multiple sclerosis	3.53e-05	0.000345	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—multiple sclerosis	2.97e-05	0.000291	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2—multiple sclerosis	2.94e-05	0.000287	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—multiple sclerosis	2.92e-05	0.000286	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MMP9—multiple sclerosis	2.78e-05	0.000272	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT3—multiple sclerosis	2.47e-05	0.000242	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MYC—multiple sclerosis	2.3e-05	0.000225	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TGFB1—multiple sclerosis	2.29e-05	0.000224	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK1—multiple sclerosis	2.25e-05	0.00022	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—multiple sclerosis	1.73e-05	0.000169	CbGpPWpGaD
